Rick Scalzo
Finanzdirektor/CFO bei DYNE THERAPEUTICS, INC.
Vermögen: 4 Mio $ am 31.05.2024
Aktive Positionen von Rick Scalzo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Verwaltungsdirektor | 01.07.2020 | - |
| Finanzdirektor/CFO | 01.07.2020 | - | |
| Treasurer | 01.07.2020 | 02.07.2020 |
Karriereverlauf von Rick Scalzo
Ehemalige bekannte Positionen von Rick Scalzo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01.08.2018 | 29.11.2019 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.09.2016 | 01.08.2018 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 01.08.2014 | 01.09.2014 |
Ausbildung von Rick Scalzo
| University of Massachusetts | Masters Business Admin |
| Boston College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Börse
- Insiders
- Rick Scalzo
- Erfahrung
